Shares outstanding · 2013–2025
Ultragenyx Pharmaceutical shares outstanding
96.6M+4.5% · FY2025
Ultragenyx Pharmaceutical (RARE) reported 96.6M in shares outstanding for fiscal 2025, +4.5% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252026-02-13 | 96.6M | +4.5% | Open → |
| FY20242025-02-13 | 92.5M | +12.4% | Open → |
| FY20232023-12-31 | 82.3M | +17.2% | Open → |
| FY20222023-02-13 | 70.2M | +1.2% | Open → |
| FY20212022-02-10 | 69.4M | +3.6% | Open → |
| FY20202021-02-08 | 66.9M | +15.7% | Open → |
| FY20192020-02-10 | 57.9M | +12.9% | Open → |
| FY20182019-02-14 | 51.3M | +16.1% | Open → |
| FY20172017-12-31 | 44.2M | +5.8% | Open → |
| FY20162017-02-13 | 41.7M | +7.3% | Open → |
| FY20152015-12-31 | 38.9M | +21.8% | Open → |
| FY20142014-12-31 | 31.9M | +747.9% | Open → |
| FY20132013-12-31 | 3.8M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +31.0%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ultragenyx Pharmaceutical shares outstanding |url=https://companiesranked.com/en/company/ultragenyx-pharmaceutical/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ultragenyx Pharmaceutical shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/ultragenyx-pharmaceutical/shares-outstandingBibTeX
@misc{companiesranked-en-company-ultragenyx-pharmaceutical-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Ultragenyx Pharmaceutical shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ultragenyx-pharmaceutical/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-057329 · February 18, 2026
{{cite web |title=Ultragenyx Pharmaceutical shares outstanding — 10-K (0001193125-26-057329) |url=https://www.sec.gov/Archives/edgar/data/1515673/000119312526057329/rare-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-18}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.